(Q30310747)

16 June 2017

title

Anti-parkinsonian agents procyclidine and ethopropazine alleviate thermal hyperalgesia in neuropathic rats (English)

1 reference

16 June 2017

2 references

3

Olney JW

1 reference

16 June 2017

Jevtovic-Todorovic V

1

1 reference

16 June 2017

Meyenburg AP

series ordinal

2

1 reference

16 June 2017

Wozniak DF

series ordinal

4

1 reference

16 June 2017

publication date

1 May 2003

1 reference

16 June 2017

1 reference

16 June 2017

volume

44

1 reference

16 June 2017

issue

6

1 reference

16 June 2017

page(s)

739-748

1 reference

Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

alpha 2 adrenergic agonists prevent MK-801 neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Painful neuropathy: altered central processing maintained dynamically by peripheral input

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Effects of oral clonidine premedication on side effects of intravenous ketamine anesthesia: a randomized, double-blind, placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Alpha-adrenoceptor-mediated antinociception and sedation in the rat and dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Alpha 2 receptors mediate the antinociceptive action of 8-OH-DPAT in the hot-plate test in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Intrathecal clonidine alleviates allodynia in neuropathic rats: interaction with spinal muscarinic and nicotinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Ketamine: an update on the first twenty-five years of clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Dose-response curves and time-course effects of selected anticholinergics on locomotor activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Behavioral effects of MK-801 in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900069-8

10.1016/S0028-3908(03)00069-8

7 January 2021

Identifiers

DOI

1 reference

16 June 2017

1 reference